<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/><title>
</title>
<style type="text/css">
			.cs2E86D3A6{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.cs5925EB86{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:normal;}
			.cs95E872D0{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.csDD5E5F52{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:normal;}
			.csED7826F6{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:14pt;font-weight:bold;font-style:italic;}
			.csE0B838BE{text-align:justify;text-indent:-86pt;margin:0pt 0pt 0pt 86pt}
			.csA16174BA{color:#000000;background-color:transparent;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;}
			.cs9224F58F{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csC970676{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.cs5ADD8C59{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:normal;font-style:normal;}
			.csE2DB38B2{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:bold;font-style:italic;}
			.cs5D3E032C{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:normal;font-style:normal;text-decoration: line-through;}
			.cs41ED3027{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csE3E0FE0B{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:italic;}
			.cs5CA3ADAD{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 54pt;line-height:12pt;mso-line-height-rule:exactly}
			.csD15247B9{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}
			.cs2C11128C{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:12pt;font-weight:normal;font-style:normal;}
			.csF0A1D375{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}
			.cs22FF6315{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:italic;}
		</style>
</head>
<body>
<p class="cs2E86D3A6"><span class="cs5925EB86">HB 120  - AS INTRODUCED</span></p><p class="cs2E86D3A6"><span class="cs5925EB86"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">2021 SESSION</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0052</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	05/06</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 108pt;"><span class="csDD5E5F52">HOUSE BILL	</span><span class="csED7826F6">120</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT	</span><a name="bkTitleDraft0"><span class="csDD5E5F52">relative to administration of psychotropic medications to children in foster care.</span></a></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">SPONSORS:	Rep. Marsh, Carr. 8; Rep. P. Schmidt, Straf. 19; Rep. Gay, Rock. 8; Rep. Salloway, Straf. 5; Rep. Crawford, Carr. 4; Rep. Schapiro, Ches. 16; Rep. Cushman, Hills. 2; Rep. Deshaies, Carr. 6; Sen. Sherman, Dist 24; Sen. Bradley, Dist 3; Sen. Rosenwald, Dist 13; Sen. Whitley, Dist 15</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">COMMITTEE:	Children and Family Law</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csA16174BA">-----------------------------------------------------------------</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">ANALYSIS</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52"> </span></p><p class="cs9224F58F" style="tab-stops:left 18pt left 86.45pt;"><span class="csDD5E5F52">	This bill requires the department of health and human services to provide medication monitoring for children in foster care and to ensure that the use of medication restraint conforms with the limitations of RSA 126-U.</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52">- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">Explanation:	Matter added to current law appears in </span><span class="csE2DB38B2">bold italics.</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">		Matter removed from current law appears [</span><span class="cs5D3E032C">in brackets and struckthrough.</span><span class="cs5ADD8C59">]</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">		Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0052</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	05/06</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">STATE OF NEW HAMPSHIRE</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">In the Year of Our Lord Two Thousand Twenty One</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT	</span><a name="bkTitleDraft1"><span class="csDD5E5F52">relative to administration of psychotropic medications to children in foster care.</span></a></p><p class="cs5CA3ADAD" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">Be it Enacted by the Senate and House of Representatives in General Court convened:</span></p><p class="csD15247B9"><span class="cs2C11128C"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt1"></a><span class="csDD5E5F52">1  New Paragraphs; Delinquent Children; Definitions Added.  Amend RSA 169-B:2 by inserting after paragraph XIII the following new paragraphs:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XIII-a  “Psychotropic medication” means a drug prescribed by a licensed medical practitioner, to treat illnesses that affect psychological functioning, perception, behavior, or mood. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XIII-b.  “Medication restraint” means the prescribing of a psychotropic medication without a clinical diagnosis for the purpose of controlling behavior.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt3"></a><span class="csDD5E5F52">2  Delinquent Children; Treatment Plan Involving the Use of Psychotropic Medication.  Amend RSA 169-B:23 to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	169-B:23  Orders for Physical Examination and Treatment.  If it is alleged in any petition, or it appears at any time during the progress of the case, that a delinquent is in need of physical treatment, the failure to receive which is a contributing cause of delinquency, due notice of that fact shall be given as provided in RSA 169-B:7.  If the court, upon hearing, finds that such treatment is reasonably required, it shall be ordered and the expense thereof shall be borne as provided in RSA 169-B:40.  </span><span class="cs22FF6315"> The use of medication restraint shall be limited as provided in RSA 126-U.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt4"></a><span class="csDD5E5F52">3  New Paragraphs; Child Protection Act; Definitions Added.  Amend RSA 169-C:3 by inserting after paragraph XXV-a the following new paragraphs:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XXV-b.  “Psychotropic medication” means a drug prescribed by a licensed medical practitioner, to treat illnesses that affect psychological functioning, perception, behavior, or mood. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XXV-c.  “Medication restraint” means the prescribing of a psychotropic medication without a clinical diagnosis for the purpose of controlling behavior.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt5"></a><span class="csDD5E5F52">4  New Paragraph; Duties of the Department of Health and Human Services Under the Child Protection Act; Oversight of Children in Foster Care Receiving Psychotropic Medication.  Amend RSA 169-C:34 by inserting after paragraph VIII the following new paragraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		IX.  The use of medication restraint shall be limited as provided in RSA 126-U.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt6"></a><span class="csDD5E5F52">5  New Paragraphs; Children in Need of Services (CHINS); Definitions Added.  Amend RSA 169-D:2 by inserting after paragraph XIII the following new paragraphs: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XIII-a.  “Psychotropic medication” means a drug prescribed by a licensed medical practitioner, to treat illnesses that affect psychological functioning, perception, behavior, or mood. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XIII-b.  “Medication restraint” means the prescribing of a psychotropic medication without a clinical diagnosis for the purpose of controlling behavior.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt7"></a><span class="csDD5E5F52">6  New Paragraph; Children in Need of Services; Oversight of Children in Foster Care Receiving Psychotropic Medication.  Amend RSA 169-D:17 by inserting after paragraph VIII the following new paragraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		IX.  The department shall ensure that, when psychotropic medication is prescribed for children in foster care, appropriate medication monitoring is provided pursuant to current American Academy of Child and Adolescent Psychiatry (AACAP) Standards.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt8"></a><span class="csDD5E5F52">7  New Subparagraph; Residential Care and Child Placing Agency Licensing; Compliance with Rules Relative to the Use of Psychotropic Medication in Children.  Amend RSA 170-E:34, I by inserting after subparagraph (h) the following new subparagraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(i)  Compliance with RSA 126-U, regarding the use of physical and medication restraint.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt14"></a><span class="csDD5E5F52">8  New Paragraphs; Services for Children, Youth and Families; Definitions Added.  Amend RSA 170-G:1 by inserting after paragraph VII the following new paragraphs:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		VIII.  “Psychotropic medication” means a drug prescribed by a licensed medical practitioner,</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">to treat illnesses that affect psychological functioning, perception, behavior, or mood.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		IX.  “Medication restraint” means the prescribing of a psychotropic medication without a clinical diagnosis for the purpose of controlling behavior.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt10"></a><span class="csDD5E5F52">9  New Paragraph; Duties of the Department of Health and Human Services; Medication Monitoring for Children in Foster Care Receiving Psychotropic Medication.  Amend RSA 170-G:4 by inserting after paragraph XXII the following new paragraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XXIII.(a)  Ensure that medication monitoring is provided for children in foster care receiving psychotropic medication pursuant to current American Academy of Child and Adolescent Psychiatry (AACAP) Standards and that any use of medication restraint conforms with the limitations in RSA 126-U.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(b)  Beginning November 1, 2022, and annually thereafter, report to the joint legislative oversight committee on health and human services established in RSA 126-A:13 regarding the use of psychotropic medications by children in foster care and compliance with the limitations on medication restraint in RSA 126-U.  Such report shall include a description of progress during the preceding fiscal year toward compliance with the recommendations of the September 2018 report of the United States Department of Health and Human Services, Office of the Inspector General entitled “Treatment Planning and Medication Monitoring Were Lacking for Children in Foster Care Receiving Psychotropic Medication.”  Such description shall include statistical information regarding the number of children in foster care, the number of such children receiving treatment with psychotropic medications, the total Medicaid expenditures for psychotropic medications for such children, and the diagnoses of such children.  In addition, the report shall include statistical information regarding the number of children in foster care receiving treatment with psychotropic medications who have treatment plans and medication monitoring as required by statute, regulation, and department procedures.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt11"></a><span class="csDD5E5F52">10  New Subparagraph; Confidentiality of Department Case Records; Access by Licensed Medical Practitioner.  Amend RSA 170-G:8-a, II(b) by inserting after subparagraph (5) the following new subparagraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(6)  A licensed medical practitioner who is overseeing the use of psychotropic medication prescribed to the child.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt12"></a><span class="csDD5E5F52">11  New Paragraph; Foster Care Children's Bill of Rights.  Amend RSA 170-G:21 by inserting after paragraph II the following new paragraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		II-a.  To receive appropriate medical supervision of any prescribed psychotropic medications.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt13"></a><span class="csDD5E5F52">12  Effective Date.  This act shall take effect January 1, 2022. </span></p></body>
</html>
